Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
90 Days	STARTED	Primary PCI Group	806
90 Days	STARTED	Abciximab Facilitated PCI Group	818
90 Days	STARTED	Reteplase/Abciximab Facilitated PCI Group	828
90 Days	COMPLETED	Primary PCI Group	793
90 Days	COMPLETED	Abciximab Facilitated PCI Group	810
90 Days	COMPLETED	Reteplase/Abciximab Facilitated PCI Group	813
90 Days	NOT COMPLETED	Primary PCI Group	13
90 Days	NOT COMPLETED	Abciximab Facilitated PCI Group	8
90 Days	NOT COMPLETED	Reteplase/Abciximab Facilitated PCI Group	15
1 Year	STARTED	Primary PCI Group	806
1 Year	STARTED	Abciximab Facilitated PCI Group	818
1 Year	STARTED	Reteplase/Abciximab Facilitated PCI Group	828
1 Year	COMPLETED	Primary PCI Group	787
1 Year	COMPLETED	Abciximab Facilitated PCI Group	804
1 Year	COMPLETED	Reteplase/Abciximab Facilitated PCI Group	816
1 Year	NOT COMPLETED	Primary PCI Group	19
1 Year	NOT COMPLETED	Abciximab Facilitated PCI Group	14
1 Year	NOT COMPLETED	Reteplase/Abciximab Facilitated PCI Group	12

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00046228/flow